Rna Analysis/Transcriptomics Market Report

Rna Analysis/Transcriptomics Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Nov 26, 2019
  • PAGES：198
  • REPORT CODE：GMM394851
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Rna Analysis/Transcriptomics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.0% during the forecast period.

    This report presents the market size and development trends by detailing the Rna Analysis/Transcriptomics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Rna Analysis/Transcriptomics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Rna Analysis/Transcriptomics industry and will help you to build a panoramic view of the industrial development.

    Rna Analysis/Transcriptomics Market, By Type:

    • Microarray

    • PCR

    • Sequencing

    • RNAi Gene Silencing

    Rna Analysis/Transcriptomics Market, By Application:

    • Clinical Diagnostics

    • Drug Discovery

    • Toxicogenomics

    Some of the leading players are as follows:

    • Bio-Rad Laboratories Inc. (U.S.)

    • Affymetrix Inc. (U.S.)

    • Qiagen N.V. (Germany)

    • Sigma Aldrich (U.S.)

    • Illumina Inc. (U.S.)

    • F. Hoffmann-La Roche Ltd. (Switzerland)

    • Agilent Technologies Inc. (U.S.)

    • Thermofisher Scientific Inc. (U.S.)

    • GE Healthcare (U.S.)

    • Fluidigm Corporation (U.S.)

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Rna Analysis/Transcriptomics Market: Technology Type Analysis

    • 4.1 Rna Analysis/Transcriptomics Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Rna Analysis/Transcriptomics Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Microarray

      • 4.3.2 PCR

      • 4.3.3 Sequencing

      • 4.3.4 RNAi Gene Silencing

    5 Rna Analysis/Transcriptomics Market: Product Analysis

    • 5.1 Rna Analysis/Transcriptomics Product Market Share Analysis, 2018 & 2026

    • 5.2 Rna Analysis/Transcriptomics Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Rna Analysis/Transcriptomics Market: Application Analysis

    • 6.1 Rna Analysis/Transcriptomics Application Market Share Analysis, 2018 & 2026

    • 6.2 Rna Analysis/Transcriptomics Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Clinical Diagnostics

      • 6.3.2 Drug Discovery

      • 6.3.3 Toxicogenomics

    7 Rna Analysis/Transcriptomics Market: Regional Analysis

    • 7.1 Rna Analysis/Transcriptomics Regional Market Share Analysis, 2018 & 2026

    • 7.2 Rna Analysis/Transcriptomics Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Bio-Rad Laboratories Inc. (U.S.)

      • 9.1.1 Bio-Rad Laboratories Inc. (U.S.) Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Affymetrix Inc. (U.S.)

      • 9.2.1 Affymetrix Inc. (U.S.) Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Qiagen N.V. (Germany)

      • 9.3.1 Qiagen N.V. (Germany) Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Sigma Aldrich (U.S.)

      • 9.4.1 Sigma Aldrich (U.S.) Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Illumina Inc. (U.S.)

      • 9.5.1 Illumina Inc. (U.S.) Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 F. Hoffmann-La Roche Ltd. (Switzerland)

      • 9.6.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Agilent Technologies Inc. (U.S.)

      • 9.7.1 Agilent Technologies Inc. (U.S.) Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Thermofisher Scientific Inc. (U.S.)

      • 9.8.1 Thermofisher Scientific Inc. (U.S.) Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 GE Healthcare (U.S.)

      • 9.9.1 GE Healthcare (U.S.) Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Fluidigm Corporation (U.S.)

      • 9.10.1 Fluidigm Corporation (U.S.) Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 104 Figures and 145 Tables)

    • Figure Microarray Rna Analysis/Transcriptomics market, 2015 - 2026 (USD Million)

    • Figure PCR Rna Analysis/Transcriptomics market, 2015 - 2026 (USD Million)

    • Figure Sequencing Rna Analysis/Transcriptomics market, 2015 - 2026 (USD Million)

    • Figure RNAi Gene Silencing Rna Analysis/Transcriptomics market, 2015 - 2026 (USD Million)

    • Figure Clinical Diagnostics market, 2015 - 2026 (USD Million)

    • Figure Drug Discovery market, 2015 - 2026 (USD Million)

    • Figure Toxicogenomics market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Rna Analysis/Transcriptomics market, by country, 2015 - 2026 (USD Million)

    • Table North America Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table North America Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table North America Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Canada Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Canada Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Europe Rna Analysis/Transcriptomics market, by country, 2015 - 2026 (USD Million)

    • Table Europe Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Europe Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Europe Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Germany Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Germany Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table France Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table France Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Italy Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Italy Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Spain Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Spain Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Rna Analysis/Transcriptomics market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table China Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table China Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Japan Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Japan Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table India Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table India Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Rna Analysis/Transcriptomics market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table MEA Rna Analysis/Transcriptomics market, by country, 2015 - 2026 (USD Million)

    • Table MEA Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table MEA Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table MEA Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Rna Analysis/Transcriptomics market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Rna Analysis/Transcriptomics market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Rna Analysis/Transcriptomics market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Bio-Rad Laboratories Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Affymetrix Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Qiagen N.V. (Germany) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sigma Aldrich (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Illumina Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table F. Hoffmann-La Roche Ltd. (Switzerland) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Agilent Technologies Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Thermofisher Scientific Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GE Healthcare (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fluidigm Corporation (U.S.) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US